Etravirine and Clopidogrel drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Etravirine (etravirine) and Clopidogrel (clopidogrel). Common drug interactions include chest pain among females and acute myocardial infarction among males.
The phase IV clinical study analyzes what interactions people have when they take Etravirine and Clopidogrel. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.
What is Etravirine?
Etravirine has active ingredients of etravirine. eHealthMe is studying from 2,801 Etravirine users. Check the latest studies of Etravirine.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.
43 people who take Etravirine and Clopidogrel together, and have interactions are studied.

What are the common drug interactions of Etravirine and Clopidogrel, by gender? *:
female:
- Chest pain
- Drug effect decreased
- Crepitations (noises are produced by the rubbing of parts one against the other)
- Diarrhoea
- Kidney infection
- Leukopenia (less number of white blood cells in blood)
- Lung disorder (lung disease)
- Neutropenia (an abnormally low number of neutrophils)
- Pneumococcal sepsis (pneumococcal sepsis is a serious medical condition where bacteria, specifically streptococcus pneumoniae)
- Proctitis herpes (inflammation of the rectum and anus by herpes)
male:
- Acute myocardial infarction (acute heart attack)
- Adverse event
- Pyrexia (fever)
- Thrombocytopenia (decrease of platelets in blood)
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Blood creatinine decreased
- Chronic kidney disease
- Drug level above therapeutic
What are the common drug interactions of Etravirine and Clopidogrel, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Acute myocardial infarction (acute heart attack)
- Adverse event
- Gastritis haemorrhagic (inflammation of stomach with bleeding)
50-59:
- Chest pain
- Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
- Drug effect decreased
- Hospitalisation
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Acute myocardial infarction (acute heart attack)
- Blood creatinine decreased
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Drug resistance (reduction in effectiveness of a drug)
- Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
60+:
- Fall
- Loss of consciousness
- Febrile neutropenia (fever with reduced white blood cells)
- Nephropathy toxic (damage to kidney due to toxins)
- Hypoxia (low oxygen in tissues)
- Lung disorder (lung disease)
- Pyrexia (fever)
- Renal failure (kidney dysfunction)
- Thrombocytopenia (decrease of platelets in blood)
- Drug level above therapeutic
What are the existing conditions these people have? *
- Hiv Infection: 36 people, 83.72%
- Heart Attack: 13 people, 30.23%
- High Blood Pressure: 6 people, 13.95%
- Acute Myocardial Infarction (acute heart attack): 5 people, 11.63%
- Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 6.98%
* Approximation only. Some reports may have incomplete information.
Do you take Etravirine and Clopidogrel?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Etravirine (2,801 reports)
- Clopidogrel (92,160 reports)
Browse all drug interactions of Etravirine and Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Etravirine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Etravirine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clopidogrel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on etravirine and clopidogrel (the active ingredients of Etravirine and Clopidogrel, respectively), and Etravirine and Clopidogrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Azithromycin and Peginterferon - 13 seconds ago
- Sandostatin Lar and Recurrent Cancer for Women aged 60+ - 20 seconds ago
- Adderall Xr 25 vs. Xanax, side effect and effectiveness comparison - 23 seconds ago
- Could Brexpiprazole cause Hyperprolactinaemia? - 25 seconds ago
- Drug interactions of Raltegravir and Zantac - 32 seconds ago
- Dry Eyes and drugs of ingredients of naltrexone - 33 seconds ago
- Breast Neoplasm and drugs of ingredients of furosemide - 38 seconds ago
- Drug interactions of Argatroban and Vitamins - 46 seconds ago
- Could Lanoxin cause Gynecomastia? - 56 seconds ago
- Nolvadex vs. Xeloda, side effect and effectiveness comparison - a minute ago